<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human interleukin-10 (h-IL-10) is a pleiotropic cytokine with stimulatory activity on B-lymphocytes </plain></SENT>
<SENT sid="1" pm="."><plain>Recent evidence indicates that <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with Epstein-Barr virus (EBV) induces h-IL-10 production in B-cells and that this cytokine may contribute to EBV-induced B-cell transformation </plain></SENT>
<SENT sid="2" pm="."><plain>It is not known whether h-IL-10 induction by EBV correlates with distinct phenotypic features of the infected cells or with the expression of particular <z:mp ids='MP_0001799'>viral</z:mp> genes </plain></SENT>
<SENT sid="3" pm="."><plain>We have approached these questions by investigating the expression of h-IL-10 mRNA in a panel of B-cell lines including: in vitro EBV-transformed lymphoblastoid cell lines (LCLs), EBV-carrying Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) lines, EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines and their sublines infected with different EBV strains, or transfected with the transformation-associated <z:mp ids='MP_0001799'>viral</z:mp> gene </plain></SENT>
<SENT sid="4" pm="."><plain>h-IL-10 mRNA was detected by reverse-transcriptase-assisted (RT)-PCR in a subset of EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> and in <z:hpo ids='HP_0000001'>all</z:hpo> EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines and LCLs investigated except Daudi </plain></SENT>
<SENT sid="5" pm="."><plain>This cell line carries an EBV nuclear antigen (EBNA)-2 gene-defective virus strain </plain></SENT>
<SENT sid="6" pm="."><plain>h-IL-10 mRNA was induced by conversion of 3 EBV-negative and h-IL-10-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines (BL41, BL47 and BL49) with the transforming, B95.8-derived EBV strain </plain></SENT>
<SENT sid="7" pm="."><plain>P3HR-I virus convertants that do not express the <z:mp ids='MP_0001799'>viral</z:mp> EBNA-2 and the EBV latent membrane protein (LMP)-1, and fail to progress towards a LCL-like <z:mp ids='MP_0005384'>cell phenotype</z:mp>, showed no evidence of h-IL-10 up-regulation </plain></SENT>
<SENT sid="8" pm="."><plain>Expression of LMP1 was sufficient to induce h-IL-10 mRNA in transfected sublines of the EBV-negative DG75 and BL41 cell lines, whereas expression of EBNA1, 2, 5, or 6 had no effect </plain></SENT>
<SENT sid="9" pm="."><plain>h-IL-10 was detected in the culture supernatants of the LMP1 transfectants by specific ELISA assays </plain></SENT>
<SENT sid="10" pm="."><plain>The present findings confirm the role of LMP1 in the transactivation of a wide variety of cellular genes which may be involved in EBV-induced B-cell transformation </plain></SENT>
</text></document>